Angpt2 has been described as surrogate of disease severity in clinical acute liver failure 65 and its relative upregulation (versus Angpt1) in murine acute-on-chronic-liver failure mediates hepatocyte dysfunction and disease via CCAAT/enhancer binding protein-β 50. The gene discussed is ANGPT1; the disease is acute liver failure.